期刊文献+

左卡尼汀对急性心肌梗死患者血清Ⅲ型前胶原氨基端肽及左室重构的影响 被引量:2

Effects of L-carnitine on serum concentration of PIIINP and left ventricular remodling in patients with acute myocardial infarction
下载PDF
导出
摘要 目的 观察左卡尼汀对急性心肌梗死(AMI)患者血清Ⅲ型前胶原氨基端肽(PⅢNP)及左室重构的影响.方法 104例AMI患者被随机分为常规治疗组(52例)和左卡尼汀治疗组(52例).两组均给予常规治疗,左卡尼汀治疗组在此基础上加用左卡尼汀3.0 g静脉滴注,每日1次,14 d为1个疗程,治疗3个疗程,每个疗程间隔2 d.用放射免疫法测定血清PⅢNP及血浆内皮素(ET)的含量.采用彩色Doppler超声心动图仪测量左室舒张末期容积指数(LEDVI)、左室收缩末期容积指数(LESVI)及左室射血分数(LVEF).结果 AMI后血清PⅢNP及血浆ET水平升高(P〈0.01).左卡尼汀治疗组在治疗4、6周时与常规治疗组相比,血清PⅢNP及血浆ET均明显减低(P〈0.05或P〈0.01),LEDVI、LESVI、LVEF较常规治疗组显著改善(P〈0.05),且6周时优于4周(P〈0.05).结论 左卡尼汀能降低AMI患者血清PⅢNP水平,改善左室重构. Objective To investigate the effect of L-carnitine on the levels of serum aminoterminal propeptide of type Ⅲ procollage (Pm NP) and left ventricular remodeling in patients with acute myocardial Infarction (AMI). Methods 104 patients with AMI were randomly divided into routine treating group (52 cases) and L-carnitine treating group (52 cases). Routine treatments were given to the two groups, and 3.0 g L-carnitine was added in the L-carnitine treating group by intravenous drip once per day for 3 courses, 14 days constituted one therapeutic course and the interval between the 2 courses was 2 days. The serum P Ⅲ NP and plasma endothelin (ET) were measured by specific radioimmunoassay. Color Doppler echocardiography was performed to determine left ventricular end diastolic volume index (LEDVI), left ventricular end systolic volume index (LESVI) and left ventricular ejection fraction (LVEF). Results After AMI, serum PmNP and plasma ET were significantly increased. In the 4th and 6th weeks serum P Ⅲ NP and plasma ET were significantly reduced in the L-carnitine treating group comparison with routine treating group. LEDVI ,LESVI and LVEF were significantly improved between the two groups and more improved in the 6th weeks than those in the 4th weeks after admission in the L-carnitine treating group. Coulusion L-carnitine can decrease the P Ⅲ NP and reverse left ventricular remodeling in patients with AMI.
出处 《中国心血管病研究》 CAS 2010年第7期503-505,共3页 Chinese Journal of Cardiovascular Research
关键词 左卡尼汀 心肌梗死 Ⅲ型前胶原氨基端肽 左室重构 L-carnitine Myocardial infarction N-terminal propeptide of type Ⅲprocollagen Ventricular remodeling
  • 相关文献

参考文献9

  • 1Cleutjens JPM,Verluyten MJA,Smits JFM,et al.Collagen remodeling after myocardial infarction in the rat heart.Am J Pathol,1995,147:325-338.
  • 2董士民,刘坤申,张晓光.急性心肌梗死患者血浆Ⅲ型前胶原氨基末端肽与左室重构及心功能关系的研究[J].中国实用内科杂志,2004,24(2):80-81. 被引量:6
  • 3Vannan MA,Taylor DJ.Ventricular remodeling after myocardial infarction.Br heart J,1992,68:257-259.
  • 4Abbate A,Biondi-Zoccai GG,Bussani R,et al.Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure.J Am Coll Cardiol,2003,41:753-760.
  • 5Uehara K,Nomura M,Ozaki Y,et al.High sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.Heart Vessels,2003,18:67-74.
  • 6Calvani M,Reda E,Arrigoni-Martelli E.Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.Basic Res Cardial,2000,95:75-83.
  • 7Fujisawa S,Kobayashi A,Hironaka Y,el al.Effects of L-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart.Jpn Heart J,1992,33:693-705.
  • 8梁孝印,邵士川,贺伟,曹玉,周茂金,王春波.左卡尼汀口服液体外抗氧化活性[J].潍坊医学院学报,2009,31(3):208-210. 被引量:7
  • 9金惠敏.左卡尼汀对血液透析中低血压和血C反应蛋白的影响[J].中国新药与临床杂志,2006,25(2):122-124. 被引量:18

二级参考文献26

  • 1夏经钢,王丽娟,胡健.左旋卡尼汀对兔在心肌缺血/再灌注损伤状态下抗氧化指标分析[J].中国医科大学学报,2006,35(4):364-366. 被引量:7
  • 2陈锦珊.左卡尼汀的临床应用进展[J].海峡药学,2006,18(6):83-85. 被引量:14
  • 3吴琼,程小卫,雷光青,陈士明,陈家宽,周铜水.仙茅苷对自由基的清除作用[J].中国现代应用药学,2007,24(1):6-9. 被引量:16
  • 4杨芬,张瑞萍,贺玖明,再帕尔·阿不力孜.羟自由基的产生、捕集及检测方法[J].药学学报,2007,42(7):692-697. 被引量:36
  • 5EVANS A.Dialysis-related carnitine disorder and levocarnitine pharmacology[J].Am J Kidney Dis,2003,41 (4 Suppl 4):S13-S26.
  • 6HUROT JM,CUCHERAT M,HAUGH M,et al.Effect of L-carnitine supplementation in maintenance hemodialysis patients:a systematic review[J].J Am Soe Nephrol 2002,13 (3):708-714.
  • 7SAVICA V,CALVANI M,BENATTI P,et al.Camitine system in uremia patients:molecular and clinical aspects[J].Semin Nephrol,2004,24 (5):464-468.
  • 8STEIBER AL,WEATHERSPOON LJ,SPRY L,et al.Serum carnitine concentrations correlated to clinical outcome parameters in chronic hemodialysis patients[J].Clin Nutr,2004,23 (1):27-34.
  • 9DEBSKA-SLIZIEN A,KAWECKA A,WOJNAROWSKI K,et al.Correlation between plasma carnitine,muscle carnitine and glycogen levels in maintenance hemodialysis patients[J].Int J Artif Organs,2000,23 (2):90-96.
  • 10CHAZOT C,BLANC C,HUROT JM,et al.Nutritional effects of carnitine supplementation in hemodialysis patients[J].Clin Nephrol,2003,59 (1):24-30.

共引文献28

同被引文献10

  • 1PurushothamanS,RenukaNairR,HarikfishnanVS,eta1.Temporalrela-tionofcardiachypertrophy,oxidativestress,andfattyacidmetabolisminspontaneouslyhypertensiverat[J].MolCellBiochem,2011,351(1-2):59-64.
  • 2NajfiM,JavidniaA,Ghorbani-HaghjoA,eta1.Pharmacologicalpre-conditioningwithL-carnitine:relevancetomyocardialhemodynamicfunctionandglycogenandlactateconten.PakJPharmSci,2010,23(3):250-255.
  • 3SoukoulisV,DihuJB,SoleM,eta1.Micronutrientdeficienciesanunmetneedinheanfailure[J].JAmCoilCardiol,2009,54(18):1660-1673.
  • 4GabyAR.Nutritionaltreatmentsforacutemyocardialinfarction[J].AlternMedRev,2010.15(2):113-123.
  • 5PurushothamanS,RenukaNairR,HarikfishnanVS,eta1.Temporalrela-tionofcardiachypertrophy,oxidativestress,andfattyacidmetabolisminspontaneouslyhypertensiverat[J].MolCellBiochem,2011,351(1-2):59-64.
  • 6NajafiM,JavidniaA,Ghorbani-HaghjoA,eta1.Pharmacologicalpre-conditioningwithL-carnitine:relevancetomyocardialhemodynamicfunctionandglycogenandlactateconten.PakJPharmSci,2010,23(3):250-255.
  • 7SoukoulisV,DihuJB,SoleM,eta1.Micronutrientdeficienciesanunmetneedinheanfailure[J].JAmCoilCardiol,2009,54(18):1660-1673.
  • 8GabyAR.Nutritionaltreatmentsforacutemyocardialinfarction[J].AlternMedRev,2010,15(2):113-123.
  • 9梁孝印,邵士川,贺伟,曹玉,周茂金,王春波.左卡尼汀口服液体外抗氧化活性[J].潍坊医学院学报,2009,31(3):208-210. 被引量:7
  • 10陈静,尹定丛.左卡尼汀的临床应用进展[J].中国医药导报,2010,7(22):9-10. 被引量:28

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部